Natixis’s Magellan Health Services, Inc. MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,389
Closed -$227K 1391
2021
Q4
$227K Buy
+2,389
New +$226K ﹤0.01% 1159
2020
Q4
Sell
-3,316
Closed -$251K 1120
2020
Q3
$251K Hold
3,316
﹤0.01% 679
2020
Q2
$242K Buy
+3,316
New +$212K ﹤0.01% 681
2018
Q2
Sell
-1,990
Closed -$213K 1026
2018
Q1
$213K Buy
+1,990
New +$200K ﹤0.01% 830
2017
Q4
Sell
-3,522
Closed -$304K 1272
2017
Q3
$304K Buy
+3,522
New +$278K ﹤0.01% 900

Natixis's MGLN Position: Q1 2022 in Review

Natixis sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 2,389 shares — an estimated $227K sold.

Natixis first reported a position in MGLN in Q3 2017 and held it in 5 quarters. The position peaked at $304K in Q3 2017. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.

  • Natixis reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
  • Natixis sold 2,389 Magellan Health Services, Inc. shares in Q1 2022, an estimated $227K.
  • Natixis first reported a position in Magellan Health Services, Inc. in Q3 2017 and held it in 5 quarters.
  • Natixis's Magellan Health Services, Inc. position peaked at $304K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.

Based on Natixis's 13F filing for Q1 2022, filed 13 May 2022.